The Value of 68Ga-grazytracer PET in Monitoring Responses to Immunotherapy of Gastrointestinal Malignancies
RecruitingOBSERVATIONAL
Enrollment
40
Participants
Timeline
Start Date
October 20, 2024
Primary Completion Date
June 30, 2026
Study Completion Date
July 31, 2027
Conditions
Gastrointestinal Malignancies
Trial Locations (1)
200001
RECRUITING
Ruijin Hospital affiliated to Shanghai Jiao Tong University of Medicine, Shanghai
All Listed Sponsors
lead
Ruijin Hospital
OTHER
NCT06644274 - The Value of 68Ga-grazytracer PET in Monitoring Responses to Immunotherapy of Gastrointestinal Malignancies | Biotech Hunter | Biotech Hunter